Moreover, the survival probability for CRC patients presenting the high and low expression of TMEM182, MCM9, and LRRFIP1 was analyzed and visualized using the TIMER2.0 platform and TCGA database (Supplementary Figure S3) [14,27]. This evidence concerns the gene TMEM182 and colorectal carcinoma.